Cargando…
Correction: Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer
Autores principales: | Chen, Yang, Liu, Weishuai, Wang, Peng, Hou, Hailing, Liu, Ningbo, Gong, Linlin, Wang, Youyou, Ji, Kai, Zhao, Lujun, Wang, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114976/ https://www.ncbi.nlm.nih.gov/pubmed/30167094 http://dx.doi.org/10.18632/oncotarget.25958 |
Ejemplares similares
-
Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer
por: Chen, Yang, et al.
Publicado: (2016) -
Inhibition of TGF-β signaling with halofuginone can enhance the antitumor effect of irradiation in Lewis lung cancer
por: Lin, Runlong, et al.
Publicado: (2015) -
Correction: Norcantharidin Inhibits Renal Interstitial Fibrosis by Blocking the Tubular Epithelial-Mesenchymal Transition
por: Li, Ying, et al.
Publicado: (2013) -
Does the response to induction chemotherapy impact the timing of thoracic radiotherapy for limited-stage small-cell lung cancer?
por: Wang, Peng, et al.
Publicado: (2015) -
Simultaneous integrated dose reduction intensity-modulated radiotherapy applied to an elective nodal area of limited-stage small-cell lung cancer
por: LIU, ZHIYAN, et al.
Publicado: (2015)